October 1, 2022 marked the official start date of our HyperProbe project. The project was selected for funding by the European Commission and will run for five years until September 30, 2027.
The “Transforming brain surgery by advancing functional-guided neuronavigational imaging” (HyperProbe) project is coordinated by Prof. Francesco Pavone from the University of Florence. The consoritum will develop a novel advanced cost-effective optical imaging system to measure brain function during surgery to achieve better guidance during brain tumour removal.
Within HyperProbe, the partners will develop a new multifunctional hyperspectral imaging device to provide real-time, quantitative, and accurate assessment of brain activity and tumour borders intraoperatively. Using an optical, contactless, and hence minimally invasive neuroimaging approach, the device will provide exhaustive biochemical information on the brain tissue and tumour features during surgery and cortical activity stimulation
The HyperProbe device will be a transportable, compact instrument allowing surgeons to easily use it, read the data it provides and integrate it with existing instrumentation. This will contribute to enhance patients’ treatments and life expectancy.
To achieve their ambitious goal, the HyperProbe consortium brings together researchers, engineers and physicists in the field of optical imaging and medical device development, computer scientists, artificial intelligence experts, neurologists, and neurosurgeons from eight academic institutions and industry partners from across Europe.
